Parameter . | Symbol . | Unit . | Estimate (SE) . |
---|---|---|---|
Growth parameters | |||
log10 initial inoculum | logcfu0 | log10 cfu/mL | 7.14 (0.3%) |
mean generation time | k12−1 | min | 42.6 (0.6%) |
replication rate constant | k21 | h−1 | 50 (fixed) |
log10 (maximum population size) | logcfumax | log10 cfu/mL | |
for untreated control arms | 10.2 (1.2%) | ||
for piperacillin-treated arms | 9.48 (0.8%) | ||
Log10 (mutant frequencies) | |||
for intermediate population | logMFI | — | −3.53 (0.9%) |
for resistant population | logMFR | — | −6.33 (0.7%) |
Inhibition of growth rate by piperacillin | |||
maximum inhibition | |||
for susceptible population | Imaxk12,S | — | 0.760 (2.9%) |
for intermediate population | Imaxk12,I | 0.970 (2.8%) | |
for resistant population | Imaxk12,R | — | 0.285 (28.4%) |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50k12,S | mg/L | 0.877 (20.9%) |
for intermediate population | IC50k12,I | mg/L | 5.96 (5.6%) |
for resistant population | IC50k12,R | mg/L | 23.7 (2.2%) |
Hill coefficient | hillk12 | — | 4.67 (10.9%) |
Inhibition of probability of successful replication by piperacillin | |||
maximum inhibition | ImaxRep | — | 1.0 (fixed)a |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50Rep,S | mg/L | 0.831 (21.9%) |
for intermediate and resistant population | IC50Rep,IR | mg/L | 45.8 (0.5%) |
Hill coefficient | hillRep | — | 2.43 (3%) |
Standard deviation of additive residual error on log10 scale | SDcfu | log10 cfu/mL | 0.259 |
Parameter . | Symbol . | Unit . | Estimate (SE) . |
---|---|---|---|
Growth parameters | |||
log10 initial inoculum | logcfu0 | log10 cfu/mL | 7.14 (0.3%) |
mean generation time | k12−1 | min | 42.6 (0.6%) |
replication rate constant | k21 | h−1 | 50 (fixed) |
log10 (maximum population size) | logcfumax | log10 cfu/mL | |
for untreated control arms | 10.2 (1.2%) | ||
for piperacillin-treated arms | 9.48 (0.8%) | ||
Log10 (mutant frequencies) | |||
for intermediate population | logMFI | — | −3.53 (0.9%) |
for resistant population | logMFR | — | −6.33 (0.7%) |
Inhibition of growth rate by piperacillin | |||
maximum inhibition | |||
for susceptible population | Imaxk12,S | — | 0.760 (2.9%) |
for intermediate population | Imaxk12,I | 0.970 (2.8%) | |
for resistant population | Imaxk12,R | — | 0.285 (28.4%) |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50k12,S | mg/L | 0.877 (20.9%) |
for intermediate population | IC50k12,I | mg/L | 5.96 (5.6%) |
for resistant population | IC50k12,R | mg/L | 23.7 (2.2%) |
Hill coefficient | hillk12 | — | 4.67 (10.9%) |
Inhibition of probability of successful replication by piperacillin | |||
maximum inhibition | ImaxRep | — | 1.0 (fixed)a |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50Rep,S | mg/L | 0.831 (21.9%) |
for intermediate and resistant population | IC50Rep,IR | mg/L | 45.8 (0.5%) |
Hill coefficient | hillRep | — | 2.43 (3%) |
Standard deviation of additive residual error on log10 scale | SDcfu | log10 cfu/mL | 0.259 |
aImaxRep was estimated at 0.994 and therefore eventually was fixed to 1.0.
Parameter . | Symbol . | Unit . | Estimate (SE) . |
---|---|---|---|
Growth parameters | |||
log10 initial inoculum | logcfu0 | log10 cfu/mL | 7.14 (0.3%) |
mean generation time | k12−1 | min | 42.6 (0.6%) |
replication rate constant | k21 | h−1 | 50 (fixed) |
log10 (maximum population size) | logcfumax | log10 cfu/mL | |
for untreated control arms | 10.2 (1.2%) | ||
for piperacillin-treated arms | 9.48 (0.8%) | ||
Log10 (mutant frequencies) | |||
for intermediate population | logMFI | — | −3.53 (0.9%) |
for resistant population | logMFR | — | −6.33 (0.7%) |
Inhibition of growth rate by piperacillin | |||
maximum inhibition | |||
for susceptible population | Imaxk12,S | — | 0.760 (2.9%) |
for intermediate population | Imaxk12,I | 0.970 (2.8%) | |
for resistant population | Imaxk12,R | — | 0.285 (28.4%) |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50k12,S | mg/L | 0.877 (20.9%) |
for intermediate population | IC50k12,I | mg/L | 5.96 (5.6%) |
for resistant population | IC50k12,R | mg/L | 23.7 (2.2%) |
Hill coefficient | hillk12 | — | 4.67 (10.9%) |
Inhibition of probability of successful replication by piperacillin | |||
maximum inhibition | ImaxRep | — | 1.0 (fixed)a |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50Rep,S | mg/L | 0.831 (21.9%) |
for intermediate and resistant population | IC50Rep,IR | mg/L | 45.8 (0.5%) |
Hill coefficient | hillRep | — | 2.43 (3%) |
Standard deviation of additive residual error on log10 scale | SDcfu | log10 cfu/mL | 0.259 |
Parameter . | Symbol . | Unit . | Estimate (SE) . |
---|---|---|---|
Growth parameters | |||
log10 initial inoculum | logcfu0 | log10 cfu/mL | 7.14 (0.3%) |
mean generation time | k12−1 | min | 42.6 (0.6%) |
replication rate constant | k21 | h−1 | 50 (fixed) |
log10 (maximum population size) | logcfumax | log10 cfu/mL | |
for untreated control arms | 10.2 (1.2%) | ||
for piperacillin-treated arms | 9.48 (0.8%) | ||
Log10 (mutant frequencies) | |||
for intermediate population | logMFI | — | −3.53 (0.9%) |
for resistant population | logMFR | — | −6.33 (0.7%) |
Inhibition of growth rate by piperacillin | |||
maximum inhibition | |||
for susceptible population | Imaxk12,S | — | 0.760 (2.9%) |
for intermediate population | Imaxk12,I | 0.970 (2.8%) | |
for resistant population | Imaxk12,R | — | 0.285 (28.4%) |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50k12,S | mg/L | 0.877 (20.9%) |
for intermediate population | IC50k12,I | mg/L | 5.96 (5.6%) |
for resistant population | IC50k12,R | mg/L | 23.7 (2.2%) |
Hill coefficient | hillk12 | — | 4.67 (10.9%) |
Inhibition of probability of successful replication by piperacillin | |||
maximum inhibition | ImaxRep | — | 1.0 (fixed)a |
concentration causing 50% of maximum inhibition | |||
for susceptible population | IC50Rep,S | mg/L | 0.831 (21.9%) |
for intermediate and resistant population | IC50Rep,IR | mg/L | 45.8 (0.5%) |
Hill coefficient | hillRep | — | 2.43 (3%) |
Standard deviation of additive residual error on log10 scale | SDcfu | log10 cfu/mL | 0.259 |
aImaxRep was estimated at 0.994 and therefore eventually was fixed to 1.0.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.